Tirbanibulin

6 trials 1 recruiting DDermatology

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

1 Recruiting

4 Completed trials

4 Sponsors

6 Countries

Phase III

Phase II/III

Phase II

Phase III/IV

Phase IV

Phase III: 1 Phase II/III: 1 Phase II: 1 Phase III/IV: 2 Phase IV: 1

Indications tested

Actinic keratosis 3 Actinic cheilitis 1 Basal cell carcinoma 1

Sponsors using this IMP

Almirall S.A. 2 Centre Hospitalier Universitaire De Nantes 2 Clinica Universidad De Navarra 1 Technische Universitat Dresden 1

All trials

6 total

Efficacy and Safety of Cryotherapy followed by Tirbanibulin ointment for actinic keratosis on the scalp and forehead Pending

2023-509931-15-00 Phase III/IV 1 country Centre Hospitalier Universitaire De Lille
Open-label, prospective study evaluating the efficacy and safety of Tirbanibulin 1% (Klisyri®) in the treatment of superficial basal cell ca… Recruiting

2023-505971-66-00 Phase II/III 1 country Centre Hospitalier Universitaire De Nice
A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Ev… Ended

2024-514394-22-00 Phase IV 5 countries Almirall S.A.
Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipient… Ended

2023-508091-11-00 Phase III/IV 1 country Clinica Universidad De Navarra
A Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibul… Ended

2023-505487-11-00 Phase III 5 countries Almirall S.A.
Exploratory study to determine the tolerability and effectiveness of Tirbanibulin in the treatment of Actinic Cheilitis - Cheilitis trial Ended

2022-502807-31-00 Phase II 1 country Technische Universitat Dresden

Showing 1–6 of 6 trials

← All drugs A–Z